A importância das vacinas na erradicação do vírus do papiloma humano (hpv) e na prevenção do câncer cervical
DOI:
https://doi.org/10.18378/rebes.v14i3.10635Abstract
This article addresses the importance of vaccines against human papillomavirus (HPV) in preventing viral infections and, consequently, in reducing the incidence of cervical cancer, one of the most common and deadly malignancies among women globally. HPV is a highly prevalent virus, with more than 200 identified types, of which types 16 and 18 are responsible for about 70% of cervical cancer cases. The introduction of bivalent, quadrivalent, and nonavalent vaccines represents a significant advancement in public health, offering specific protection against the most oncogenic HPV types. In this context, the objectives of this study include analyzing the effectiveness of vaccines in preventing HPV infections, reducing precancerous lesions, and decreasing the incidence of cervical cancer. Furthermore, it seeks to identify the main challenges in implementing vaccination programs and evaluate the public policies that have been adopted to promote vaccination in various populations. The results obtained indicate that vaccination against HPV is highly effective in preventing infections by the HPV types included in the vaccines, demonstrating a significant reduction in the incidence of precancerous lesions, such as cervical intraepithelial neoplasia (CIN). Selected articles showed that countries with established vaccination programs report a sharp decline in high-grade CIN rates and an initial decrease in cervical cancer incidence among young vaccinated women. The effectiveness of the vaccines, combined with well-structured vaccination programs and educational campaigns, has the potential to transform global public health, significantly reducing the burden of HPV-associated diseases and improving the quality of life for affected populations.
Downloads
References
ARALDI, R. P. et al. The human papillomavirus (HPV)-related cancer biology: An overview. Biomedicine & pharmacotherapy, v. 106, p. 1537-1556, 2018.
ATHANASIOU, A. et al. HPV vaccination and cancer prevention. Best Practice & Research Clinical Obstetrics & Gynaecology, v. 65, p. 109-124, 2020.
BARRA, F. et al. New prophylactics human papilloma virus (HPV) vaccines against cervical cancer. Journal of Obstetrics and Gynaecology, v. 39, n. 1, p. 1-10, 2019.
BOGANI, G. et al. The role of human papillomavirus vaccines in cervical cancer: Prevention and treatment. Critical Reviews in Oncology/Hematology, v. 122, p. 92-97, 2018.
CALUMBY, R. J. N. et al. Papiloma Vírus Humano (HPV) e neoplasia cervical: importância da vacinação. Brazilian journal of health Review, v. 3, n. 2, p. 1610-1628, 2020.
CAMPOSI, R. S. P; SOUZAI, L. B. L. N. Gestação e papilomavírus humano (HPV): vias de transmissão e complicações. Aposente-se com mais tranquilidade para seu futuro, conte com o nosso serviço de assessoria INSS, p. 109, 2016.
CARDIAL, M. F. T. et al. Papilomavírus humano (HPV). Femina, p. 94-100, 2019.
CARVALHO, N. S. de et al. Protocolo Brasileiro para Infecções Sexualmente Transmissíveis 2020: infecção pelo papilomavírus humano (HPV). Epidemiologia e Serviços de Saúde, v. 30, p. e2020790, 2021.
CHENG, L.; WANG, Y. ; DU, J. Human papillomavirus vaccines: an updated review. Vaccines, v. 8, n. 3, p. 391, 2020.
DALLA LIBERA, L. S. Avaliação da infecção pelo Papiloma Vírus Humano (HPV) em exames citopatológicos. Brazilian Journal of Clinical Analysis, v. 48, n. 2, p. 138-43, 2016.
FERREIRA, H.; LALA, E. R. P.; MANSOUR, F. R. Frequência de Papilomavirus Humano (HPV) em gestantes. Biológicas & Saúde, v. 7, n. 25, 2017.
GARCÍA-PERDOMO, H. A. et al. The effectiveness of vaccination to prevent the papillomavirus infection: a systematic review and meta-analysis. Epidemiology & Infection, v. 147, p. e156, 2019.
GUPTA, G.; GLUECK, R; PATEL, P. R. HPV vaccines: Global perspectives. Human vaccines & immunotherapeutics, v. 13, n. 6, p. 1421-1424, 2017.
HANCOCK, G.; HELLNER, K.; DORRELL, L. Therapeutic HPV vaccines. Best practice & research Clinical obstetrics & gynaecology, v. 47, p. 59-72, 2018.
HARPER, Diane M.; DEMARS, Leslie R. HPV vaccines–a review of the first decade. Gynecologic oncology, v. 146, n. 1, p. 196-204, 2017.
KAMOLRATANAKUL, S.; PITISUTTITHUM, P. Human papillomavirus vaccine efficacy and effectiveness against cancer. Vaccines, v. 9, n. 12, p. 1413, 2021.
LEI, J. et al. HPV vaccination and the risk of invasive cervical cancer. New England Journal of Medicine, v. 383, n. 14, p. 1340-1348, 2020.
LOWY, D. R. et al. HPV vaccination to prevent cervical cancer and other HPV-associated disease: from basic science to effective interventions. The Journal of clinical investigation, v. 126, n. 1, p. 5-11, 2016.
LUZ, R. M. G; GONZALES, M. F; ODA, J. M. M. Papilomavirus humano (HPV) e terapêutica. Archives of Health Investigation, v. 7, 2018.
MARKOWITZ, L. E.; SCHILLER, J. T. Human papillomavirus vaccines. The Journal of infectious diseases, v. 224, n. Supplement_4, p. S367-S378, 2021.
MARTINS, C. M.; FRIDMAN, F. Z; MAGNO, V. Papilomavírus humano (HPV). São Paulo: Federação Brasileira das Associações de Ginecologia e Obstetrícia (FEBRASGO), p. 31-47, 2021.
MEDRADO, K. S.; SANTOS, M. de O.; FILHO, A. V. M. Papiloma vírus humano (hpv): revisão bibliográfica. Saúde & ciência em ação, v. 3, n. 2, p. 52-63, 2017.
MOURA, L. de L; CODEÇO, C. T; LUZ, P. M. Cobertura da vacina papilomavírus humano (HPV) no Brasil: heterogeneidade espacial e entre coortes etárias. Revista brasileira de epidemiologia, v. 24, p. e210001, 2020.
MURILLO, R. ; ORDÓÑEZ-REYES, C. Human papillomavirus (HPV) vaccination: from clinical studies to immunization programs. International Journal of Gynecologic Cancer, v. 29, n. 8, 2019.
OLIVEIRA, C. R.; NICCOLAI, L. M. Monitoring HPV vaccine impact on cervical disease: Status and future directions for the era of cervical cancer elimination. Preventive medicine, v. 144, p. 106363, 2021.
PATHAK, P.; PAJAI, S.; KESHARWANI, H. A Review on the Use of the HPV Vaccine in the Prevention of Cervical Cancer. Cureus, v. 14, n. 9, 2022.
PETROSKY, E. et al. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep, v. 64, n. 11, p. 300-304, 2015.
RADECKI, C. B et al. Awareness and knowledge of Human Papillomavirus (HPV), HPV‐related cancers, and HPV vaccines in an uninsured adult clinic population. Cancer Medicine, v. 5, n. 11, p. 3346-3352, 2016.
REES, C. P.; BRHLIKOVA, P.; POLLOCK, A. M. Will HPV vaccination prevent cervical cancer?. Journal of the Royal Society of Medicine, v. 113, n. 2, p. 64-78, 2020.
RIZZO, E. R et al. Vacina do HPV-o conhecimento das adolescentes a respeito do Papiloma vírus Humano, um relato de experiência. Revista Pró-UniverSUS, v. 7, n. 2, p. 10-12, 2016.
ROCHA, N. M. et al. Papilomavírus humano (HPV) e uso do preservativo: conhecimento de jovens brasileiros. Caderno de Graduação-Ciências Biológicas e da Saúde-UNIT-ALAGOAS, v. 7, n. 1, p. 89-89, 2021.
SANKARANARAYANAN, R. HPV vaccination: The most pragmatic cervical cancer primary prevention strategy. International Journal of Gynecology & Obstetrics, v. 131, p. S33-S35, 2015.
SCHELLENBACHER, C.; RODEN, R. B. S; KIRNBAUER, R. Developments in L2-based human papillomavirus (HPV) vaccines. Virus research, v. 231, p. 166-175, 2017.
SILVA, L. E. L. da; OLIVEIRA, Maria Liz Cunha de; GALATO, Dayani. Receptividade à vacina contra o papilomavírus humano: uma revisão sistemática. Rev Panam Salud Publica; 43, feb. 2019, 2019.
STANLEY, M. Preventing cervical cancer and genital warts–How much protection is enough for HPV vaccines?. Journal of Infection, v. 72, p. S23-S28, 2016.
STILLO, M.; SANTISTEVE, P. C. ; LOPALCO, P. L. Safety of human papillomavirus vaccines: a review. Expert opinion on drug safety, v. 14, n. 5, p. 697-712, 2015.
WANG, C. J.; PALEFSKY, J. M. Human papillomavirus (HPV) infections and the importance of HPV vaccination. Current epidemiology reports, v. 2, p. 101-109, 2015.
WILLIAMSON, A. Recent developments in human papillomavirus (HPV) vaccinology. Viruses, v. 15, n. 7, p. 1440, 2023.
YOUNG, D. et al. Increase in head and neck cancer in younger patients due to human papillomavirus (HPV). Oral oncology, v. 51, n. 8, p. 727-730, 2015.
ZANINI, N. V. et al. Motivos para recusa da vacina contra o Papilomavírus Humano entre adolescentes de 11 a 14 anos no município de Maringá-PR. Revista Brasileira de Medicina de Família e Comunidade, v. 12, n. 39, p. 1-13, 2017.
Downloads
Published
Versions
- 2024-07-22 (2)
- 2024-07-19 (1)
How to Cite
Issue
Section
License
Copyright (c) 2024 Adriane Barbosa de Sousa , Anna Paula de Oliveira Simiema , Jaira Maria Martins Petrônio , Amanda Anawate de Oliveira , Letícia de Souza Formiga , Poliana de Lima Santana Rocha , Francisco Juniele Soares Ribeiro , Jamily Lucena Salviano
![Creative Commons License](http://i.creativecommons.org/l/by/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Termo de cess